Sort
10,766 grants matching “checkpoint inhibitor”
Project 1: Targeting immunotherapy-induced resistance with DC vaccination and PD-1/CSF-1R inhibition
$372,200Robert M Prins · University Of California Los Angeles · P50 · FY2022 · CA
Project 2: Targeting DNA replication in BRCA-associated breast cancer
$372,142Bing Xia · Rbhs -Cancer Institute Of New Jersey · P01 · FY2022 · CA
MOLECULAR CARCINOGENESIS IN THE MOUSE AND HUMAN PROSTATE
$372,066Pier Paolo Pandolfi · Sloan-Kettering Inst Can Research · P50 · FY2007 · CA
Reprogramming the tumormicroenvironment to improve immunotherapy of glioblastoma
$372,041Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2023 · CA
Project 3: Hedgehog Inhibition to Enhance Response to ICI Therapy
$372,036Ronald J Buckanovich · University Of Pittsburgh At Pittsburgh · P50 · FY2023 · CA
Project 1: Active immunotherapy combined with checkpoint modulation for glioblastoma
$371,981Robert M Prins · University Of California Los Angeles · P50 · FY2018 · CA
Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers
$371,925Matthias Stephan · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA
Targeted Arf1 inhibition to enhance immune response in oral cancer
$371,905Yong Teng · Emory University · R01 · FY2024 · DE
The role of Angiopoietin-like 4 in clear cell renal cell carcinoma and its therapeutic potential
$371,905Ryan H Kolb · University Of Florida · R01 · FY2025 · CA
Targeted Arf1 inhibition to enhance immune response in oral cancer
$371,905Yong Teng · Emory University · R01 · FY2025 · DE
Genetic regulation of genome stability in yeast
$371,743Thomas D Petes · Duke University · R01 · FY2007 · GM
Project 1: Genomic Predictors of Clinical Outcomes and Response to Targeted Therapy in Advanced Prostate Cancer
$371,700David B. Solit · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA
Functional Analysis of p53 Polymorphic Variants
$371,666Maureen E Murphy · Wistar Institute · R01 · FY2024 · CA
Inherent tropism and/or immune modulation in melanoma brain metastasis
$371,660Lucia Beatrice Jilaveanu · Yale University · R01 · FY2019 · CA
Integration of neo-antigen vaccines and immune checkpoint therapy
$371,552Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2024 · CA
Ciprofloxacin enhances DNA repair capacity after radiation combined injury
$371,512Juliann Gong Kiang · Henry M. Jackson Fdn For The Adv Mil/Med · R33 · FY2011 · AI
Germ-line miRNA binding site variants as biomarkers of toxicity and response to checkpoint inhibition
$371,444Joanne B Weidhaas · University Of California Los Angeles · R01 · FY2019 · CA
Germ-line miRNA binding site variants as biomarkers of toxicity and response to checkpoint inhibition
$371,444Joanne B Weidhaas · University Of California Los Angeles · R01 · FY2020 · CA
Germ-line miRNA binding site variants as biomarkers of toxicity and response to checkpoint inhibition
$371,444Joanne B Weidhaas · University Of California Los Angeles · R01 · FY2021 · CA
Dissecting and targeting oncogenic functions of PAK4 in high-risk rhabdomyosarcoma
$371,359Jason Yustein · Emory University · R01 · FY2023 · CA
Cytotoxic lymphocyte function PET imaging to predict cancer immunotherapy response
$371,351Umar Mahmood · Massachusetts General Hospital · R01 · FY2019 · CA
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma
$371,300Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2020 · NS
Project 1: Overcoming Tumor-Induced Immune Suppression to Improve Responses to Immunotherapy
$371,255David G Denardo · Washington University · P50 · FY2018 · CA
Regulation of repetitive elements in cancer by P53 and epigenetic mechanisms
$371,226Katherine B Chiappinelli · George Washington University · R37 · FY2025 · CA
Project 2: Targeting DNA replication in BRCA-associated breast cancer
$371,188Bing Xia · Rutgers Biomedical And Health Sciences · P01 · FY2023 · CA